PRDM1

From Wikipedia, the free encyclopedia
PRDM1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesPRDM1, BLIMP1, PRDI-BF1, PR domain 1, PR/SET domain 1
External IDsOMIM: 603423 MGI: 99655 HomoloGene: 925 GeneCards: PRDM1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001198
NM_182907

NM_007548

RefSeq (protein)

NP_001189
NP_878911

NP_031574

Location (UCSC)Chr 6: 105.99 – 106.11 MbChr 10: 44.44 – 44.53 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

PR domain zinc finger protein 1, or B lymphocyte-induced maturation protein-1 (BLIMP-1), is a protein in humans encoded by the gene PRDM1 located on chromosome 6q21.[5] BLIMP-1 is expressed in both B and T cells and plays a significant role in B cell development and antibody production. In B cells, it is a regulator of plasma cell differentiation. In T cells, it is crucial for most terminal effector cell differentiation in CD 4 and CD8 T cells. BLIMP-1 acts as a repressor of beta-interferon (β-IFN) gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the β-IFN gene promoter. Transcription of this gene increases upon virus induction.[6]

Function[]

BLIMP-1 is an important regulator of plasma cell differentiation. Except for naïve and memory B cells, all antibody secreting cells express BLIMP-1 regardless of their location and differentiation history. In the absence of BLIMP-1, proliferating B cells are unable to differentiate to plasma cells, resulting in severe reduction in production of all isotypes of immunoglobulin. [5]

The increased expression of the Blimp-1 protein in B lymphocytes, T lymphocytes, NK cell and other immune system cells leads to an immune response through proliferation and differentiation of antibody secreting plasma cells. Blimp-1 is also considered a 'master regulator' of hematopoietic stem cells.[7][8] Other cells of the immune system such as human peripheral blood monocytes and granulocytes also express BLIMP-1. In a monocytic cell line, over-expression of BLIMP-1 can lead to differentiation into mature macrophages. BLIMP-1 also plays a role in osteoclastogenesis as well as in the modulation of dendritic cells.

As a transcriptional repressor, BLIMP-1 has a critical role in the foundation of the mouse germ cell lineage, as its disruption causes a block early in the process of primordial germ cell formation. BLIMP-1-deficient mutant embryos form a tight cluster of about 20 primordial germ cell-like cells, which fail to show the characteristic migration, proliferation and consistent repression of homeobox genes that normally accompany specification of primordial germ cells. The genetic lineage-tracing experiments indicate that the BLIMP-1-positive cells originating from the proximal posterior epiblast cells are indeed the lineage-restricted primordial germ cell precursors.[9]

B cell development[]

During B cell development, a B cell can either differentiate into a short-lived plasma cell or into a germinal center B cell after receiving proper activation and co-stimulation. BLIMP-1 acts as a master gene regulating the transcriptional network that regulates B cell terminal differentiation. BLIMP-1 expression is carefully controlled, since premature expression of it in primary B cells results in cell death. Thus, only cells that are ready to initiate transcription driven by BLIMP-1 are able to survive and differentiate.[5][10]

T cell development[]

BLIMP-1 plays a key role in maintaining normal T cell homeostasis. It regulates T cell responsiveness through repression of IL-2 cytokine in a negative feedback loop. T cell activation results in production of IL-2. IL-2 signaling then leads to PRDM1 transcription and BLIMP-1 feeds back to repress IL-2 gene transcription.[5]

T cell exhaustion[]

BLIMP-1 helps the production of short-lived effector T cells and clonally exhausted T cells. It also helps with the migration of T cells out of the spleen and lymph nodes into peripheral tissues. However, BLIMP-1 does not promote the production of long-lived effector memory cells. BLIMP-1 allows the production of some longer lived effector memory cells but its absence allows for the generation of long term central memory cells, which are thought to have a higher potential of proliferation on secondary challenge.[11]  

Second cancers after radiation treatment[]

A genome-wide association study has identified two genetic variations near the PRDM1 gene that predict an increased likelihood of developing a second cancer after radiation treatment for Hodgkin lymphoma.[12]

References[]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000057657 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038151 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b c d Boi M, Zucca E, Inghirami G, Bertoni F (May 2015). "PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas". Leukemia & Lymphoma. 56 (5): 1223–8. doi:10.3109/10428194.2014.953155. PMID 25115512.
  6. ^ "Entrez Gene: PRDM1 PR domain containing 1, with ZNF domain".
  7. ^ Turner CA, Mack DH, Davis MM (April 1994). "Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells". Cell. 77 (2): 297–306. doi:10.1016/0092-8674(94)90321-2. PMID 8168136. S2CID 46200658.
  8. ^ Sciammas R, Davis MM (May 2004). "Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation". Journal of Immunology. 172 (9): 5427–40. doi:10.4049/jimmunol.172.9.5427. PMID 15100284.
  9. ^ Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, Sano M, et al. (July 2005). "Blimp1 is a critical determinant of the germ cell lineage in mice". Nature. 436 (7048): 207–13. Bibcode:2005Natur.436..207O. doi:10.1038/nature03813. PMID 15937476. S2CID 4399840.
  10. ^ Fu SH, Yeh LT, Chu CC, Yen BL, Sytwu HK (July 2017). "New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function". Journal of Biomedical Science. 24 (1): 49. doi:10.1186/s12929-017-0354-8. PMC 5520377. PMID 28732506.
  11. ^ Welsh RM (August 2009). "Blimp hovers over T cell immunity". Immunity. 31 (2): 178–80. doi:10.1016/j.immuni.2009.08.005. PMC 3220184. PMID 19699168.
  12. ^ Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, et al. (July 2011). "Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma". Nature Medicine. 17 (8): 941–3. doi:10.1038/nm.2407. PMC 3229923. PMID 21785431. Lay summaryUniversity of Chicago Medical Center. {{cite journal}}: Cite uses deprecated parameter |lay-url= (help)

Further reading[]

External links[]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Retrieved from ""